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Abstract
Background:   Major histocompatibility complex (MHC) molecules present peptides to T
lymphocytes. It is of critical biological and medical importance to elucidate how different MHC
alleles bind to a specific set of peptides.
Method:  In this study we approach the problem from the algebraic and geometric point of view
to analyse MHC-peptide-binding data accumulated over the years. The space of sequence
properties (having a particular amino acid at a particular position) of MHC-peptide complexes
conveys a geometric structure to these sequence properties in the form of a distance measure,
which reveals the peptide binding requirements imposed by the polymorphic sequence
characteristics of the MHC molecules.
Results:  Comparison of the results of this study with our current knowledge of MHC-peptide
binding constraints leads to robust agreement. This study provides the tools to quantitate these
binding constraints giving a more detailed account of them and opening the way to make peptide
binding predictions for MHC alleles for which there is no peptide elution data. In addition, the
geometric representation of MHC-peptide complex sequence data gives a distance measure
between amino acids in reference to their ability to meet MHC binding requirements.
Conclusions:  The algebraic and geometric view of amino acid sequences provides a theoretical
framework to study the function of proteins when there is enough variation in this sequence to
account for the variation in their function, as it is the case with MHC molecules in regard to their
ability to present peptides.
Background
The cellular immune response depends on antigen pres-
entation to T cells by major histocompatibility complex
(MHC) molecules, the antigens presented being small
peptides with amino acid sequence limitations deter-
mined by the MHC alleles carried by a particular individ-
ual. In the study of the immune response it is of critical
importance to discover the laws governing which pep-
tides can be presented by which MHC alleles. As peptide
receptors, major histocompatibility complex (MHC)
molecules are capable of binding different peptides; but
each MHC molecule–each allele–exhibits a predilection
for a set of peptides with distinct sequence characteris-
tics. From crystallographic studies of MHC-peptide com-
plexes, as well as from sequence analysis of peptides
eluted from these complexes, we learn that MHC genetic
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polymorphism is responsible for the differences in pep-
tide binding between MHC molecules. [1, 2, 3, 4, 5, 6] We
claim that peptide selection by a given MHC allele can be
presented as a function of the MHC sequence, instead of
the current approach to this problem which consists in a
function of the allele in question. By setting the amino
acids that occupy the different positions in the MHC
molecule as the arguments of this function instead of a
mere reference to an allele, the door is open to make gen-
eralizations from available elution data to include those
cases in which no empirical data is yet available.
Over the past decade data on peptide binding to the MHC
molecule have been accumulating. [7, 8] Do these data
provide by themselves–that is, independently of other
data such as crystallographic and chemical-sufficient in-
formation to characterise the requirements imposed by
the various MHC alleles on what kind of peptide can be
presented to T cells? The problem at hand consists in
finding the proper theoretical framework to look at and
analyse the sequences of these MHC-peptide complexes.
We claim geometry provides this theoretical framework.
Amino acid sequences can be represented as vectors in a
metric space. [9] It is the essence of this metric space that
two sequences are at a distance of each other. Our analyt-
ical tools are the transformations we can impose on this
metric space to manipulate the distances between se-
quences, that is, between MHC-peptide complexes.
With the duality principle in geometry and the concept of
dual spaces we move from a space of distances between
amino acid sequences populated by MHC-peptide com-
plexes to a space populated by the sequence properties of
these complexes. In this new space we can measure the
distance between the properties of the MHC-peptide
complexes rather than the distances between the com-
plexes themselves. Looking at the data in this light we
can see how the sequence of the MHC molecule affects
the sequence restrictions for the peptide allowed to bind
to the molecule. This is revealed in the form of proximi-
ties between certain sequence properties of the MHC
molecule and those of the bound peptide.
In this study we concentrate on the class I human leuco-
cyte antigen (HLA) molecules and nonameric peptides
bound to them.
The algebraic and geometric structure of MHC-
peptide complexes
Let S be the space of MHC-peptide complexes. In this
space each MHC-peptide complex is a point, represented
by the vector of their amino acid sequence properties, the
values the point takes in the co-ordinates of the space.
The co-ordinates (dimensions) of this space correspond
to these sequence properties, both peptide sequence
properties and MHC sequence properties (only polymor-
phic positions in the MHC α 1 and α 2 domains are includ-
ed). Peptide binding data allows the population of this
space with ×  points. These ×  points are represented by
matrix M of size ×  n, where n is the dimensionality of the
space, that is, the total number of sequence properties,
and each row is the vector representing each point. (In
this study peptide binding data included 2535 nonameric
peptides known to bind alleles HLA-A1, HLA-A11, HLA-
A3, HLA-A2, HLA-A24, HLA-A25, HLA-A33, HLA-A31,
HLA-A30, HLA-A29, HLA-B45, HLA-B44, HLA-B35,
HLA-B53, HLA-B51, HLA-B14, HLA-B8, HLA-B38,
HLA-B13, HLA-B27, HLA-B7, HLA-B42, HLA-854,
HLA-CW2, and HLA-CW4, obtained from the MHCPEP
database.) [8]
Now, let S' be the x-dimensional space of the sequence
properties of the MHC-peptide complexes. Each point in
this space corresponds to a property of the type 'MHC-
peptide complex has amino acid x, at position pi', where
pi can be either in the peptide or in the MHC molecule.
Each dimension in this space corresponds to a particular
MHC-peptide complex. We say S' is the transposed
space of S. S is a space of particulars (molecules) and S'
is a space of universals (sequence properties). The n
points in S' are represented by matrix M' of size n × ,
where each row is the vector representing each point. M'
is the transposed matrix of M. (See Fig. 1) The points in
S become co-ordinate axes in S' and the co-ordinate axes
in S become points in S'.
To give an example, let us define the sequence properties
x, y and z (coordinates or dimensions in space S) as: x ≡
'having> amino acid D in peptide position 3', y ≡  'having
amino acid E in peptide position 3', and z ≡  'having ami-
no acid Y in peptide position 9'. Let us also define the
MHC-peptide complexes a, b, c and d (points in space S)
as; a ≡  [HLA-A*0101-IADMGHLKY], b ≡  [HLA-A*0101-
STEPVNILY], c ≡  [HLA-A*2402-TYSAGIVQI], and d ≡
[HLA-A*0207-LLDVPTAAV]. Then, ignoring all other
points and dimensions, space S of MHC-peptide com-
plexes is defined as: S = {a(1,0,1), b(0,1,1), c(0,0,0),
d(1,0,0)}, where each point is defined by its coordinates
and the values of these coordinates indicate that a prop-
erty holds true ('1') or that it does not ('0'). Space S can
then be represented by the matrix:BMC Structural Biology (2001) 1:2 http://www.biomedcentral.com/1472-6807/1/2
where each row represents a point (an MHC-peptide
complex) in the space with its three coordinates. And the
transposed space S' of sequence properties is defined as
S' = {x (1,0,0,1), y(0,1,0,0,), z(1,1,0,0,)}, and it can be
represented by the matrix:
where each row represents a point (a sequence property)
in the space with its four coordinates. It can be seen that
the matrix of space S' is the transposed matrix of space S.
For this reason we call S' the 'transposed space' of S.
This conversion is similar to the conversion of the sen-
tence 'peptide i has amino acid Y at position 2' to the sen-
tence 'having amino acid Y at position 2 is a
characteristic of peptide i'. The subject and the predicate
in the first sentence become the predicate and the subject
in the second sentence respectively. There is a duality
principle at work here. As Ramsey indicates, there is no
sense in the distinction between 'individual' and 'quality',
or between 'particular' and 'universal', the two types be-
ing in every way symmetrically related. [10] The conver-
sion of S into S' by transposing M allows the
measurement of the distance between the points in S',
that is between the sequence properties of MHC-peptide
complexes. Particularly, we are interested in the distance
Figure 1
SPACE S' is the transposed space of SPACE S, the points in the latter become coordinates in the former, the co-ordinates in the
latter become points in the former.BMC Structural Biology (2001) 1:2 http://www.biomedcentral.com/1472-6807/1/2
between sequence properties specific of the peptide and
sequence properties specific of the MHC molecule. The
distance between the sequence characteristics of the
MHC molecule and those of the peptide has the potential
of revealing how peptides bind to MHC molecules and
how sequence requirements are imposed by the different
MHC alleles on peptides as binding candidates.
Our data unit is the MHC-peptide complex. We define
two types of categorical variables of the MHC-peptide
complex. First, variables of the following type: amino
acid Paa is present at position Pp in the peptide-these
variables we call 'p' and the set of them all 'P'. Second,
variables of the type: amino acid Haa is present at posi-
tion Hp in the MHC molecule-these variables we call 'h'
and the set of them all 'H'. In other words, a partition of
space S' (we call 'K') is made to separate the class of pep-
tide sequence properties (P) from the class of MHC se-
quence properties (H), so that K = {P, H}, S' = P ∪  H and
P ∩  H = Θ . The variables or properties we are talking
about- 'having amino acid threonine at position 9 in the
peptide', for instance-are bipolar: a peptide either has
that amino acid at that position or it has not. In the case
of MHC sequence properties, only polymorphic posi-
tions in the alpha 1 and 2 domains are considered. There-
fore, nonamers are characterised by 180 sequence
properties, one for each of the 20 amino acids at each of
the nine positions; and MHC alleles are characterised by
207 sequence properties for each of the possible amino
acids at each one of the 73 polymorphic positions in the
alpha-1 and alpha-2 domains. Only some amino acids are
found at each polymorphic site; for instance, at position
65 the amino acids G, Q and R can be found in various al-
leles; at position 90, only A and D; etc.
A function D of the Cartesian product H ×  P into R (the
line of real numbers) gives the distance between every
pair (h, p) of sequence properties of MHC molecules and
peptides bound to them. That is, D: H ×  P →  R where D
= {(h, p, D(h, p))| h ∈  H, p ∈  P}. (See Fig. 2) In other
words, this function takes two arguments: one is an HLA
sequence property (e.g. 'having amino acid E at position
46 in the HLA molecule'), and the other argument is a
peptide sequence property (e.g. 'having amino acid P at
position 2 in the peptide'). The value returned by this
function is a distance measure. In measuring the dis-
tance between two such properties-points or vectors in
S'-there are various alternatives. We use the Ochiai sim-
ilarity index defined as: [11]
where a is the number of MHC-peptide complexes where
both h and p hold, b the number of complexes where h
holds but p dos not, c the number of complexes where h
does not hold but p does, and d the number of cases
where neither h or p hold. In other words, a, b, c and d
are the cells in a 2 ×  2 contingency table. This similarity
index ranges from 0 to 1. In this study the values re-
turned by function D were such that only 1% were greater
than 0.4, 0.1% were greater than 0.6, and 0.03% were
greater than 0.8. Measures of similarity and measures of
dissimilarity- distance-can be linked to each other by
means of 'similarity functions'. [11] In this study we may
talk about similarity measures, but conceptually it is dis-
tances we are dealing with.
To give a concrete example, let us consider the following
sequence properties: h 1  ≡  'having amino acid Q at MHC
position 65', h 2  ≡  'having amino acid N at MHC position
66', p 1  ≡  'having amino acid P at peptide position 2', p
2  ≡  'having amino acid G at peptide position 5', p 3  ≡
'having amino acid I at peptide position 6'. The values
returned by function D for the corresponding members
of H ×  P are as follows:
That is, for the first row, there are 57 MHC-peptide com-
plexes in our database where at the MHC position 65
there is a Q and at peptide position 2 there is a P; there
are 270 cases where at the MHC position 65 there is a Q
but at peptide position 2 there is not a P; there are 2 cases
where at the MHC position 65 there is not a Q and at pep-
tide position 2 there is a P; and there are 524 cases where
at the MHC position 65 there is not a Q and at peptide
position 2 there is not a P. The D value for these two se-
quence properties is 0.33. Etc.
A relation L(d 1, d 2 ) is defined on the function D so that
two elements d 1 (h 1 , p 1 ) and d 1 (h 1 , p 2 ) are related if
h 1 and h2 are sequence properties characteristic of the
same MHC allele, where h 1 and h 2 are members of H, p
1 and p 2 are members of P and d 1 and d 2 are members
of D. This relation is not an equivalence relation because
although it is reflexive and symmetric, it is not transitive.
Therefore the relation L(d 1 , d 2 ) does not lead to a par-
tition of D, but to a collection Q of overlapping subsets.
Each element of Q-subset of D defined by L-represents
itself an MHC allele. (See Fig. 3)BMC Structural Biology (2001) 1:2 http://www.biomedcentral.com/1472-6807/1/2
On each element q i of Q-subset of D corresponding to a
particular MHC allele-we define relation N so that two
elements of D in q i are related if the distance returned by
function D corresponds to the same peptide sequence
property p ∈  P. Relation N is an equivalence relation that
defines a partition on q i. Let Ui(N) be the partition de-
fined by N on q i, this partition will have at most 180
equivalence classes, one corresponding to each peptide
sequence property p ∈  P. In saying that N is defined on q
i rather than on Q we are actually considering the prod-
uct or intersection of two relations: L ∩  N. Since L is not
an equivalence relation, nor is L ∩  N, and it does not lead
to a partition of Q.
Let function V of Q into R180 (180-dimensional real-
number space) return a vector for each MHC allele q i.,
member of Q, with the maximum value d = D(h, p) in
each equivalence class of partition Ui(N). This R  180
space we call Y and is the metric space of MHC alleles
where each axis corresponds to a peptide sequence prop-
erty (20 amino acids and 9 peptide positions), and each
point in this space is an MHC allele. (See Fig. 4) Function
V returns an 180-dimension vector. The co-ordinate val-
ue each MHC allele-each point in Y-assumes in each axis
is a measure of predilection of the peptides to be bound
to that allele for that corresponding peptide sequence
property of that axis. If the property is, for instance, hav-
ing glutamic acid at position 2 in the peptide, alleles that
allow peptides with glutamic acid at position 2 will have
a high value as their co-ordinate in that axis, and those
alleles that do not will have a low value. The vector rep-
resenting each allele in Y is in fact equivalent to the 20 ×
9 'matrix' or table of 'average relative frequencies' or
'binding affinities' that characterise the sequence of pep-
tides that bind to an allele.
By giving these data an algebraic and geometric structure
we can answer such questions as: 'Which amino acids
and in which positions in the MHC molecule are involved
in defining peptide binding requirements?', and also
'How different are amino acids in peptides in regard to
meeting the binding constraints imposed by the MHC?'
Results
Effect of HLA polymorphism on peptide sequence require-
ments
The study of function D reveals the binding properties of
HLA-peptide complexes. This study consists in the ex-
Figure 2
FUNCTION D, mapping of the cartesian product H ×  P into R (the real-number line).BMC Structural Biology (2001) 1:2 http://www.biomedcentral.com/1472-6807/1/2
amination of the distribution of the values returned by
function D for the various values that the arguments of
the function take. For instance, it shows that positions 2
and 9 in the peptide are critical in determining binding,
position 2 carrying with it the highest values by far.
These positions have been called 'anchor positions'. Next
in importance are positions 1 and 3. Positions 4, 5, 6, 7
and 8 appear to play a very secondary role if they play
one at all. The only exception to this finding is what takes
place with allele HLA-B27. Only this allele carries with it
high similarity values with peptide positions between 3
and 9. Whereas other alleles have requirements that af-
fect which amino acids are at positions 2, 9, 1 and 3 (in
order of stringency in the requirements), but not at the
other positions in the peptide. HLA-B27 imposes re-
quirements that in addition affect which amino acids oc-
cupy positions between 3 and 9. This was observed
because the complete set of HLA sequence variables with
high similarity values at positions between 3 and 9 corre-
spond exactly to the sequence of HLA-B27.
As given by function D, high similarity measures (Ochiai
Index > 0.7) for position 2 in the peptide show all but one
(position 66) of the polymorphic positions in the HLA
molecule described by Chelvanayagam as the 'peptide
binding environment' for this position in the peptide: 7,
9, 24, 25, 26, 34, 35, 36, 45, 62, 63, 66, 67, 70, 99,
159, 163,167 (polymorphic positions in bold). [12] Other
positions (32, 41, 65, 97, 113 and 158) have high similar-
ity measures suggesting a possible role in the selection of
the amino acids that are to occupy this position in the
peptide.
Figure 3
RELATION L, defined on function D so that two elements d 1 (h 1 , p 1 ) and d 2 (h 2 , p 2 ) are related if h 1 and h 2 are sequence
properties characteristic of the same MHC allele. Collection Q is the set of elements in D related to each other according to
L; since L is not an equivalence relation, Q is not a partition.BMC Structural Biology (2001) 1:2 http://www.biomedcentral.com/1472-6807/1/2
Similarity measures for position 9 in the peptide are low-
er than for position 2, by using a lower cutoff (Ochiai In-
dex > 0.4) function D shows the majority (all except 77,
80, 81 and 143) of the polymorphic positions in Chelva-
nayagam's 'peptide binding environment' for this posi-
tion in the peptide: 70, 73, 74, 76, 77, 80, 81, 84, 95,
96, 97, 114,116, 123, 124, 142,143, 146, 147 (polymor-
phic positions in bold). Other positions (62, 66, 67, 107,
127, 145 and 158) appear to have high similarity meas-
ures suggesting a possible role in the selection of the ami-
no acids that are to occupy position 9 in the peptide.
Function D also shows other peculiarities of MHC-pep-
tide binding such as the fact that a basic amino acid (K,
R, H) at position 9 in the peptide is associated with the
presence of aspartic acid at positions 74, 77 and 116 in the
HLA molecule. This had been previously observed by
Vasmatzis and co-workers. [13]
Distance between amino acids
Previously we defined a theoretical concept of amino
acid distance in terms of the dissimilarity between the
chemical properties of amino acids. [9] If we could meas-
ure the distance between amino acids in peptides bound
to HLA molecules in reference to how they are selected
and restricted by the HLA molecule itself to allow bind-
ing, then we would have a useful measuring instrument
to tell how different peptides themselves are in their abil-
ity to bind to HLA molecules.
This can be accomplished by studying the distribution of
values returned by function D depending on the amino
Figure 4
FUNCTION V of Q into Y, returns the 180-dimension vector of peptide binding affinities for each MHC allele.BMC Structural Biology (2001) 1:2 http://www.biomedcentral.com/1472-6807/1/2
acid in each position of the peptide (Paa) and ignoring
their position (Pp). In other words, we have defined a
partition of D in which each equivalence class corre-
sponds to an amino acid. Doing so we obtain a vector for
each amino acid with each value in the vector represent-
ing a measure of the distribution of the values of function
D, such as the average, for each HLA sequence variable
(h ∈  H). In this way we have created a new space we call
X-Paa where the amino acids that constitute peptides
are represented as vectors and the HLA sequence varia-
bles as co-ordinate axes.
The distances between amino acids in this space X-Paa
show at a high level-small distance- three distinct clus-
ters: 1) tyrosine, phenylalanine and tryptophan; 2) ser-
ine, valine and threonine; and 3) isoleucine, methionine
and leucine. At a lower level-allowing clusters to form
with a greater distance between its members-new clus-
ters appear, like the one formed by glutamine and ar-
ginine; but then other clusters start to overlap and
become ill-defined, like the supercluster formed by ami-
no acids alanine, serine, valine, threonine, lysine, isoleu-
cine, methionine and leucine. These patterns in space X-
Paa show that the distance measure defined in it is co-
herent. It is difficult to give a theoretical account for
these distance measures in terms of known amino acid
characteristics, but close to a third of the variability of
the distance between amino acids in this space can be ex-
plained in terms of their chemical structure and their
size, as determined by multiple regression analysis be-
tween the empirical distance matrix of X-Paa, as inde-
pendent variable, and two theoretical distance matrices
as dependent variables based on 1) molecular weight,
and 2) chemical properties (hydrophobicity, polarity,
charge, etc.). This regression analysis gives a coefficient
of determination of R2 = 27.5%, which increases to R2 =
29.0% when chemical characteristics are represented as
separate variables. Analysis of variance to study the ef-
fect of each variable independently of the others shows
that, apart from the molecular weight, the chemical char-
acteristics that appear to play a major role are the pres-
ence of an aromatic ring or an amide group, or whether
the amino acid is a base positively charged; other charac-
teristics, such as presence of an -OH or an -SH group, ap-
pear to play a less important role.
In our previous study we defined amino acid distances in
terms of their chemical characteristics. In the present
study we have been able to measure amino acid distance
in empirical terms in regard to the ability of peptide ami-
no acids to meet peptide binding requirements. That this
empirical distance measure is coherent is shown by the
distinct clusters of amino acids it leads to. In trying to
give an account of this empirical distance we find that it
can be partially explained in terms of both the theoretical
chemical distance scheme we had previously developed
and the amino acid molecular weight. As several authors
had already pointed out, [14, 15, 16] it is not just the
chemical characteristics of amino acids, but their size
too, that allows them to fit appropriately in the peptide-
binding groove of the MHC molecule. The three distinct
amino acid clusters identified ({Y, F, W}, {S, V, T} and {I,
M, L}) throw some light into what it is about amino acids
in the peptide that MHC molecules recognise as critical
in determining binding. Although valine and leucine are
very similar in their chemical structure, they are in dif-
ferent clusters. It appears that it is the molecular weight
that separates them in spite of their almost identical
chemical structure. In fact, the three clusters that stand
out in our study could be separated solely based on mo-
lecular weight if the rest of the amino acids are not taken
into account. The proximity of methionine to leucine and
isoleucine indicates that the presence of sulphur in me-
thionine does not make any difference in peptide bind-
ing. It is remarkable to find valine (a non-polar amino
acid) in the same cluster as serine and threonine (polar
amino acids). The same thing with tyrosine (a polar ami-
no acid) that is in the same cluster as phenylalanine and
tryptophan (non-polar). The definition of the {Y, F, W}
cluster indicates the importance of aromatic rings in de-
termining peptide binding for that is precisely what de-
fines this cluster. One is tempted to conclude that
chemical structure- whether an amino acid has an
aliphatic chain or an aromatic ring, for instance-is more
important than polarity.
The amino-acid distance described in the paper is 'bi-
ased' in the sense that it only applies to differences in
amino acids in reference to how they determine peptide
binding to the HLA molecule. This cannot be extrapolat-
ed to the influence of an amino acid in any other protein
for any other function.BMC Structural Biology (2001) 1:2 http://www.biomedcentral.com/1472-6807/1/2
Peptide-binding profiles for HLA alleles
By representing HLA alleles as vectors in space Y as the
mapping created by function V (see above) the door is
open to make peptide binding predictions using the tra-
ditional algorithms for this task [17, 18] as the vectors in
space Y are equivalent to the 'binding-affinity' or 'pep-
tide-side-chain-frequency' matrices [19, 20] used by
these algorithms. Space Y is created from data in which
the reference to the alleles peptides bind to has been sub-
stituted with the amino acid sequence of those alleles. In
this way predictions can be made not only for HLA alleles
for which there is elution data available, but also for
those alleles for which there is no elution data, in so far
as the latter share sequence characteristics with the
former.
Empirical binding-affinity matrices for each allele can be
represented in another space Z with the same dimen-
sions as Y. The difference between Y and Z is that Z con-
tains points only for HLA alleles for which there is
peptide binding data, whereas Y has points representing
all alleles, even those without peptide binding data avail-
able, as long as their sequences have homologies with al-
leles with peptide binding data. While space Z comes
from amino acid frequency counts at various peptide po-
sitions for different alleles, space Y comes from distances
between sequence properties, by transposing S into S'
and looking at sequence properties of HLA -peptide
complexes instead of looking at the complexes them-
selves. For example the vector for HLA-B55 in Y is given
in Table 21. This allele was not considered to have
Table 1: Vector for allele HLA-B55 in space Y. 
Amino Peptide amino acid position
Acid P1 P2 P3 P4 P5 P6 P7 P8 P9
A 0.25 0.16 0.16 0.20 0.17 0.18 0.18 0.17 0.12
C 0.10 0.05 0.14 0.11 0.04 0.11 0.06 0.06 0.03
D 0.17 0.04 0.17 0.16 0.12 0.10 0.08 0.09 0.03
E 0.16 0.16 0.09 0.13 0.10 0.08 0.11 0.32 0.02
F 0.27 0.12 0.24 0.13 0.13 0.14 0.14 0.08 0.22
G 0.15 0.14 0.10 0.15 0.12 0.14 0.11 0.13 0.09
H 0.09 0.16 0.11 0.09 0.11 0.13 0.13 0.07 0.10
I 0.16 0.14 0.20 0.12 0.12 0.20 0.13 0.19 0.35
K 0.13 0.05 0.18 0.15 0.39 0.12 0.13 0.13 0.43
L 0.21 0.26 0.15 0.18 0.15 0.17 0.18 0.16 0.32
M 0.13 0.09 0.11 0.03 0.08 0.05 0.21 0.08 0.15
N 0.11 0.08 0.09 0.13 0.12 0.14 0.08 0.10 0.09
P0 . 0 6 0.84 0.18 0.15 0.23 0.11 0.15 0.22 0.04
Q 0.15 0.08 0.08 0.30 0.07 0.22 0.15 0.10 0.03
R 0.42 0.71 0.29 0.18 0.16 0.16 0.16 0.12 0.23
S 0.14 0.14 0.12 0.13 0.19 0.26 0.10 0.16 0.04
T 0.14 0.18 0.13 0.15 0.12 0.11 0.37 0.16 0.06
V 0.11 0.26 0.19 0.11 0.13 0.13 0.19 0.13 0.23
W 0.05 0.07 0.08 0.13 0.06 0.08 0.13 0.07 0.10
Y 0.12 A 0.25 0.42 0.10 0.08 0.14 0.16 0.08 0.25
APRQPGLMA
APRTVALTA
APRQPGLMA
APRTVALTA
RPRH Q GVMV
IPY HIV NIV
APTGDLPRA
The top part of the table shows the vector for allele HLA-B55, of size 180, represented as a matrix. (Data for this allele was not used to build the 
models in this study.) The bottom part of the table shows the sequence of seven nonameric peptides known to bind to HLA-B55. Highlighted in bold 
are the points of agreement between the model and the sequence of these peptides.BMC Structural Biology (2001) 1:2 http://www.biomedcentral.com/1472-6807/1/2
enough elution data to be included in the model to create
space Y, so its vector is solely based on data from other
alleles.
In order to evaluate the prediction made in Table 21
about the sequence of peptides likely to bind to HLA-
B55, we have calculated the likelihood ratio (LR) of the
prediction made for each position in a nine-amino-acid
peptide as derived from 2 ×  2 contingency tables. First we
determine a cut-off, values of 0.23 or above are consid-
ered positive predictions, that is, they indicate that the
corresponding amino acid is a likely candidate to appear
in a collection of peptides known to bind to HLA-B55;
values below 0.23 are negative predictions. At position 1
(P1) 3 amino acids (A, F and R) were predicted to be
found in such peptides. In the small collection of pep-
tides presented, 3 amino acids are found at that position
(A, R, and I). Therefore we have 2 true positives (TP), A
and R; 1 false positive (FP), F; 1 false negative (FN), I;
and 16 true negatives (TN), the rest of the amino acids.
The likelihood ratio for this position is LR = (2/(2+1))/
(1/(1+16)) = 11.33. For position P2 we have TP = 1; FP =
4; FN = 0; TN = 15; and LR = 4.75. For position P3 we
have TP = 2; FP = 1; FN = 1;TN = 16; and LR = 11.33. For
position P4 we have TP = 1; FP = 0; FN = 3; TN = 17; the
LR cannot be calculated because the specificity is 100%,
although the sensitivity is only 25%. For position P5 we
have TP = 1; FP = 1; FN = 4; TN = 14; and LR = 3. For po-
sition P9 we have TP= 1; FP = 6; FN = 1; TN = 12; and LR
= 1.52. Considering that by random we get a LR = 1, like-
lihood ratios above 1, some as high as 11, indicate that the
prediction has some substance; especially when the LRs
are multiplied with each other as they are to be.
In trying to make peptide binding predictions for alleles
without peptide elution data, the question is how good a
substitute of Z Y is. Regression analysis was used to an-
swer this question, with the vectors representing HLA-
alleles in space Y as the independent variable, and those
vectors representing the same alleles in space Z as the de-
pendent variable. In addition, the numerical values of
vectors in Y and Z were converted to categorical values
and then the pairs of vectors were compared using 2 ×  2
contingency tables. (See Table 32.)
Table 2: Comparison of allele vectors in spaces Y and Z.
HLA Numerical Categorical
allele R2 (%) Sensitivity (%) Specificity (%) Likelihood Ratio
A1 27.1 50 97 15
A2 71.9 67 100
A3 63.7 50 98 22
A11 40.5 50 97 18
A24 25.8 100 97 36
A29 12.7 67 95 13
A31 26.8 100 97 30
A33 16.0 100 96 25
B7 36.6 60 94 10
B8 14.4 50 95 10
B14 22.9 50 94 9
B27 71.8 100 99 86
B35 36.9 100 97 30
B38 0.2 0 93
B44 18.3 25 96 6
B51 48.6 100 98 45
B53 22.4 67 97 20
B54 40.9 67 98 30
ALL 27.7 64 96 18
'R2' stands for the coefficient of determination in the regression analysis of numerical values of the vectors in spaces Y and Z (see text) for each 
allele. (In all cases the p value was 0.000, except for B38, which was 0.51.) Allele vectors values in Y and Z were converted to categorical values (0, 
1) using cut-off values and pairs of vectors for each allele were compared using a 2 ×  2 contingency table. 'Sensitivity', 'specificity', and 'likelihood 
ratio' refer to the prediction of a Z vector by the corresponding Y vector, and were calculated from these 2 ×  2 tables.B
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2 Table 3: Predicted peptide-binding motifs for HLA class I alleles without sufficient binding data to make direct predictions.
Pp Paa A23 A26 A32 A34 A36 A43 A66 A68 A69 A74 B62 B75 B72 B63 B37 B61 B41 B46 B48 B49 B50 B52 B55 B57 B58 859 B67 B73 B78 B81
1 A 0.3 0.3 0.3 0.3 0.3 0.3 8.3 0.3 0.3 0.3 0.3 0.3
1 F 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0-3 0.3 0.3 0.3 0,3 0,3 0,3 0,3
1 R 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.4 0.3 0.3 0.3 0.3 0.3 0.4 0.3 0.3 0,3 04 0.3 0.3 0.4 0.4 0.5 0.3 0.4
2 E 0.5 0.7 0.7 0.7 0.7 0.7 0.7 0.7 0.7 0.7 0.7
2F 0 . 3
2 I 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3
2 L 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.4 0.5 0.5 0.4 0.5 0.5 0.3 0.3 0.5 0.5 0.3 0.5 0.5 0.3 0.4
2 P 0.5 0.8 0.5 0.8 0.3 0.5 0.8 0.8 0.8 0.5 0.8 0.8 0.8 0.8 0.7 0.8 0.8 0.8 0.8 0.6 0.6 0.8 0.8 0.8 0,8 0.8 0.8 0.8 0.8 0.8
2 R 0.4 0.4 0.4 0,4 0.4 0,4 0.4 0.5 0.5 0.7 0.5 0.5 0.5 0.5 0.5 0.7 0.5 0.5 0.5 07 0.5 0.5 0.7 0.7 0.9 0.5 07
2 T 03 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3
2 V 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3
2 Y 0.7 0.5 0.5 0.5
3 D 0.3 0.4 0.3 0.4 0.4 0.4
3 F 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0,3 0.3
3K 0.3 0.3
3 R 0.3 0.4 0.4 0.3 0.4 0.3 0.3 0.4
3 Y 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 04 0.3 0.3 0.3 0.3 0.3 0.4 0.3 0.3 0.3 0,4 0.3 0.3 0.4 0.4 0.5 0.3 0.4
3 I 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.4 0.4 0.3 0.3 0.4 0.3 0.4 0.4 0.3
3 K 0.4 0.5 0.5 0.4 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.4 0.4 0.5 0.5 04 0.4 0.4 0.4
9 L 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 03 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3
9 R 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3
8 V 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.3 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.3 0.4 0.4 0.3
9 Y 0.3 0.6 0.4 0.3 0.6 0.6 0.4 0.4 0.4 0.4 0.6 0.3 0.3 0.6 0.6 0.3 0.3 0.3 0.3
Peptide-binding motifs are based on allele vectors in space Y. 
Only values for the Ochiai similarity index equal or greater than 0.3 are included. 
'Pp' stands for amino acid position in peptide and 'Paa' for the amino acid occupying that position.BMC Structural Biology (2001) 1:2 http://www.biomedcentral.com/1472-6807/1/2
It is clear that the peptide-binding profiles for alleles
without experimental elution data cannot be accurate. It
is also clear that an approximate prediction can in fact be
made for the complete range of class I HLA alleles, the
accuracy of the prediction depending on the sequence
similarities with alleles for which there is elution data.
Table 43 shows tentative predictions of peptide-binding
motifs for alleles without sufficient binding data to make
direct predictions, based on their respective vectors in
space Y.
MHC pocket classes and peptide-binding motifs
The fact that co-ordinate values in S' are bipolar opens
the door to the use of propositional logic. Space S' is not
only the space of peptide and HLA sequence properties,
which, from the point of view of logic, are considered el-
ementary or atomic propositions; but also the space of all
possible propositional functions based on the former el-
ementary propositions. We are interested in two types of
functions, those that take their arguments from HLA se-
quence properties (H), functions of the form f 1(h 1, h 2,
..., h n); and functions that take their arguments from
peptide sequence properties (P), functions of the form f
II(p 1, p 2, ..., p m). The latter (f II) are what in the immu-
nology literature are called 'peptide-binding motifs', the
former (fI) can be, for instance, the MHC pocket classes
Zhang and co-workers describe. [16]
Just as we can measure the distance between two prop-
erties h and p in S', we can also measure the distance be-
tween two propositional functions f  I and f  II. For
instance, if we define the following elementary sequence
properties h 1 ≡  (H p  = 45, Haa = 'M'), h 2 , ≡  (H p  = 45,
Haa = 'T'), h 3  ≡  (H p  = 67, Haa = 'V'), h 4  ≡  (H p  = 67,
Haa = 'M'), h 5  ≡  (H p  = 66, Haa = 'N'), p1≡  (Pp = 2, Paa
= 'V'), p 2  ≡  (Pp = 2, Paa = 'S'), and p 3 = (Pp = 2, Paa =
'T'), the distance between f I = (h 1∨  h 2 ) and (h 3∨  h 4)
and h 5 and f II = p 1∨  p 2 ∨  p 3 is 0.48, measured as an
Ochiai similarity index, a value reached in less than 1% of
the distances measured in space S' indicating unusual
proximity. In this case f I is the Zhang MHC pocket class
'P2-IV.2', and f II is the restriction of position 2 in the
Table 4: Distance between logical combinations of HLA and peptide sequence properties. 
MHC HLA sequence variables Peptide sequence variables Similarity index
pocket class (distance)
P2-I.1 Hp = 9, Haa = Y Pp = 2, Paa = P 0.90
Hp = 66, Haa = I
Hp = 67, Haa = Y or F
P2-III.1 Hp = 45, Haa = D or E Pp = 2, Paa = R or H or K 0.73
P2-IV.1 Hp = 45, Haa = M Pp = 2, Paa = L or I or M 0.63
Hp = 63, Haa = E
Hp = 66, Haa = K
Hp = 67, Haa = V
P2-IV.2 Hp = 45, Haa = M or T Pp = 2, Paa = V or S or T 0.48
Hp = 66, Haa = N
Hp = 67, Haa = V or M
P2.-V.1 Hp = 9, Haa = S or V Pp = 2, Paa = Y or F or W 0.85
Hp = 63, Haa = E or Q
Hp = 66, Haa = K or R
PΩ -I Hp= 116, Haa = Y or F or L Pp = 9, Paa = I or M or L or V 0.59
PΩ -II.1 Hp= 116, Haa = D Pp = 9, Paa = K or R 0.73
Hp = 74, Haa = D
Hp = 77, Haa = D
PΩ -II.2 Hp = 116, Haa = D Pp = 9, Paa = K or R 0.63
Hp = 74, Haa = D
PΩ -III Hp = 116, Haa = D or S Pp = 9, Paa = Y or F or W or L or 
I or M
0.19
Hp = 74, Haa = D or Y
PΩ -III Hp = 116, Haa = D or S Pp = 9, Paa = K or R or Y 0.63
Hp = 74, Haa = D or Y
HLA molecule.- Hp: position number; Haa: amino acid. Peptide.- Pp: position number, Paa: amino acid. For the similarity index (Ochiai index), '1' 
means total similarity and '0' total absence of similarity; in our study only 4% of distance measurements between isolated sequence variables had an 
index greater than 0.2, 1% had an index greater than 0.4, 0.1% had an index greater than 0.6, and only in 0.03% of measurements the index was 
greater than 0.8.BMC Structural Biology (2001) 1:2 http://www.biomedcentral.com/1472-6807/1/2
peptide (Pp = 2) to the {S, V, T} amino acid cluster. See
Table 54 for other such distance measurements between
f I-type and f II-type propositional functions, that is, be-
tween HLA pocket classes and peptide-binding motifs.
By the use of propositional logic, and by making a geo-
metric representation of logical propositions, which al-
lows the measurement of the distance between them, we
have a convenient tool to study peptide binding in terms
of the sequence characteristics of MHC molecules and
peptides.
The amino acids favoured at position 2 in the peptide for
the various HLA pocket classes defined by Zhang et al.
provides additional evidence for the amino acid clusters
we have identified. The amino acid cluster {S, V, T} is fa-
voured in the Zhang pocket class P2-IV.2, the cluster {I,
M, L} in the pocket class P2-IV.1, and the cluster {Y, F,
W} in the pocket class P2-V.1.
Conclusions
By looking at the problem of peptide binding to the MHC
molecule from an algebraic and geometric perspective,
molecules and their properties are seen as vectors in a
metric space in which distances can be measured. A
range of analytical tools then become available to study
these distances, from which important conclusions can
be drawn. The positions in the MHC molecule that deter-
mine peptide binding requirements are revealed. How
different peptide amino acids are in meetings those re-
quirements becomes clear. And we can define allelic pep-
tide-binding profiles in terms of the amino acid sequence
of the MHC allele, allowing the prediction of peptide
binding for alleles for which there is no binding data as
long as they have sequence similarities with alleles for
which there is. At this time these predictions are limited
by the fact that the correlation of allele vectors in spaces
Y and Z is not perfect; but being able to make predictions
at all marks the way to use current peptide data to make
inferences for alleles for which there is no such data. We
should emphasise that all the results presented here
were derived automatically, without any input of previ-
ous knowledge of the biological question at hand. Our
findings come directly and strictly from an automatic
data analysis of the MHCPEP data. By means of the ana-
lytical methods introduced here knowledge accumulated
by many researchers over many years has been repro-
duced. In addition, these methods have brought to light
new facts about peptide binding.
A major limitation in this study is that variables (se-
quence properties) are assumed to be independent of
each other in their effect on peptide binding, when there
is good reason to believe they are not. Dropping the as-
sumption of independence, however, comes at a very
high cost by increasing the computational complexity of
the problem to such a magnitude that makes it apparent-
ly intractable. Future progress in elucidating how pep-
tides are selected for their presentation to T cells
depends on the development of algorithms to analyse
peptide binding data in a combinatorial way that would
account for the possibility that the effect of MHC se-
quence variables is interrelated. Here we have shown
that a propositional calculus can be developed to repre-
sent any such combination of sequence variables, f I-type
propositional functions for MHC sequence variables and
f  II-type propositional functions for peptide sequence
variables. We have also shown that the study of all the
possible combinations of variables amounts to evaluat-
ing how these two types of functions- f I and f II-hold to-
gether in the space S' of empirical data.
Geometry, as the study of abstract spaces, results from
the distinction between 'set' and 'space'. A space differs
from the mere set of the elements that populate the space
by possessing a structure that places the elements of the
space in a certain relation with each other. The elements
in the space-points, vectors-are close or far from each
other, there is a distance between them. By defining a
distance measure between the elements of a set we con-
fer a geometric structure to that set converting it into a
space. If we can tell how different MHC alleles are from
each other– how distant they are–in reference to a par-
ticular function, let us say, their ability to present pep-
tides of a specific amino acid sequence, we are actually
converting the set of MHC alleles into a metric space
where a distance measure has been defined. Now, we can
similarly define a distance measure between MHC alleles
in terms of their sequence differences. In fact we can de-
fine many such distance measures by changing the 'scale'
of the co-ordinates, that is, by changing the 'weight' a
variable (co-ordinate) has in contributing to the distance
measure-each new measure being the result of a trans-
formation imposed on that space. If we find which trans-
formation in the sequence space of MHC molecules
results in a distance measure that best parallels-corre-
lates more closely with-the distance measure in the func-
tional space of MHC molecules, we have a geometric
model of the function of MHC molecules in terms of their
amino acid sequences.
In this paper we talk about the 'transposed space' as the
result of transposing the matrix of vectors in the se-
quence space of MHC-peptide complexes. This matrix
operation creates a dual space where the n dimensions in
the original space become the points-vectors-in the new
space, and the ×  vectors in the original space become the
dimensions-co-ordinates-in the new space. By doing so
we convert the distance measure between MHC-peptide
complexes into a distance measure between their se-
quence properties. This last concept-the distance be-BMC Structural Biology (2001) 1:2 http://www.biomedcentral.com/1472-6807/1/2
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tween the sequence properties of MHC-peptide
complexes-is a key that opens the door to elucidate the
peptide binding requirements imposed by the MHC ami-
no acid sequence.
We conclude that algebra and geometry provide a con-
venient theoretical framework to study the function of
proteins as amino acid sequences when there is enough
variation in this sequence to account for the variation in
their function, as we have seen to be the case with MHC
molecules in regard to their ability to present peptides.
The algebraic and geometric concepts presented here are
the foundation for the design of an information model to
create a database and the algorithms to manipulate it.
They are not presented for the sake of advancing a
unique and peculiar theory, but with an entirely practical
intent. Although databases and computer programmes
are typically presented as implementations, it is prefera-
ble to present them formally in mathematical terms so
that their true nature comes to light. The theoretical con-
cepts presented here allowed us to manipulate MHC-
peptide-binding data in a successful manner.
Although in this paper we have centred our attention on
the conceptualisation of the problem and on the method-
ological aspects of data analysis, we are aware that the re-
sults presented here depend on the quality of empirical
data used in the analysis. A critical review of the data sets
currently available [7,8,21] indicate that careful auditing
of the data, as well as continuous compilation of new em-
pirical data are necessary.
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